200 related articles for article (PubMed ID: 6517950)
1. Hexadecane increases the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): is brown adipose tissue the primary target in TCDD-induced wasting syndrome?
Rozman K
Biochem Biophys Res Commun; 1984 Dec; 125(3):996-1004. PubMed ID: 6517950
[TBL] [Abstract][Full Text] [Related]
2. Histopathology of interscapular brown adipose tissue, thyroid, and pancreas in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
Rozman K; Pereira D; Iatropoulos MJ
Toxicol Appl Pharmacol; 1986 Mar; 82(3):551-9. PubMed ID: 3952737
[TBL] [Abstract][Full Text] [Related]
3. Separation of wasting syndrome and lethality caused by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Rozman K
Toxicol Lett; 1984 Sep; 22(3):279-85. PubMed ID: 6485001
[TBL] [Abstract][Full Text] [Related]
4. Brown adipose tissue is a target tissue in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity.
Rozman K; Strassle B; Iatropoulos MJ
Arch Toxicol Suppl; 1986; 9():356-60. PubMed ID: 3468916
[TBL] [Abstract][Full Text] [Related]
5. Effect of a sublethal dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin on interscapular brown adipose tissue of rats.
Rozman K; Pereira D; Iatropoulos MJ
Toxicol Pathol; 1987; 15(4):425-30. PubMed ID: 3432942
[TBL] [Abstract][Full Text] [Related]
6. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thermogenesis in brown adipose tissue of rats.
Weber LW; Haart TW; Rozman K
Toxicol Lett; 1987 Dec; 39(2-3):241-8. PubMed ID: 3686553
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma corticosterone levels and histopathology of the adrenals and thymuses in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats.
Gorski JR; Muzi G; Weber LW; Pereira DW; Iatropoulos MJ; Rozman K
Toxicology; 1988 Dec; 53(1):19-32. PubMed ID: 3201474
[TBL] [Abstract][Full Text] [Related]
8. Han/Wistar rats are exceptionally resistant to TCDD. I.
Pohjanvirta R; Tuomisto J; Vartiainen T; Rozman K
Pharmacol Toxicol; 1987 Feb; 60(2):145-50. PubMed ID: 3575248
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormones modulate the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Rozman K; Rozman T; Scheufler E; Pazdernik T; Greim H
J Toxicol Environ Health; 1985; 16(3-4):481-91. PubMed ID: 4087313
[TBL] [Abstract][Full Text] [Related]
11. Subchronic oral toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the guinea pig: comparisons with a PCB-containing transformer fluid pyrolysate.
DeCaprio AP; McMartin DN; O'Keefe PW; Rej R; Silkworth JB; Kaminsky LS
Fundam Appl Toxicol; 1986 Apr; 6(3):454-63. PubMed ID: 3084328
[TBL] [Abstract][Full Text] [Related]
12. Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity.
Rozman K; Rozman T; Greim H
Toxicol Appl Pharmacol; 1984 Feb; 72(2):372-6. PubMed ID: 6695381
[TBL] [Abstract][Full Text] [Related]
13. Role of the endocrine system in the action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the thymus.
van Logten MJ; Gupta BN; McConnell EE; Moore JA
Toxicology; 1980; 15(2):135-44. PubMed ID: 7376192
[TBL] [Abstract][Full Text] [Related]
14. Persistent, low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effect on aryl hydrocarbon receptor expression in a dioxin-resistance model.
Franc MA; Pohjanvirta R; Tuomisto J; Okey AB
Toxicol Appl Pharmacol; 2001 Aug; 175(1):43-53. PubMed ID: 11509025
[TBL] [Abstract][Full Text] [Related]
15. Relationship of the wasting syndrome to lethality in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Christian BJ; Inhorn SL; Peterson RE
Toxicol Appl Pharmacol; 1986 Feb; 82(2):239-55. PubMed ID: 3945951
[TBL] [Abstract][Full Text] [Related]
16. Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J and DBA/2J mice.
Chapman DE; Schiller CM
Toxicol Appl Pharmacol; 1985 Mar; 78(1):147-57. PubMed ID: 4035666
[TBL] [Abstract][Full Text] [Related]
17. Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Gorski JR; Muzi G; Weber LW; Pereira DW; Arceo RJ; Iatropoulos MJ; Rozman K
Toxicol Pathol; 1988; 16(3):313-20. PubMed ID: 3057589
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific alterations of de novo fatty acid synthesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
Gorski JR; Weber LW; Rozman K
Arch Toxicol; 1988; 62(2-3):146-51. PubMed ID: 3196149
[TBL] [Abstract][Full Text] [Related]
19. Screening of pharmacological agents given peripherally with respect to TCDD-induced wasting syndrome in Long-Evans rats.
Pohjanvirta R; Tuomisto J; Vikkula K
Pharmacol Toxicol; 1988 Oct; 63(4):240-7. PubMed ID: 2973575
[TBL] [Abstract][Full Text] [Related]
20. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) kills glucocorticoid-sensitive thymocytes in vivo.
McConkey DJ; Orrenius S
Biochem Biophys Res Commun; 1989 May; 160(3):1003-8. PubMed ID: 2543382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
